Compare BioNTech SE - ADR (BNTX) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Recursion Pharmaceuticals Inc — how do they compare? BioNTech SE - ADR trades at $90.4 (market cap $22.78B), while Recursion Pharmaceuticals Inc trades at $3.36 (market cap $1.75B). The key difference: BioNTech SE - ADR is far larger — about 13× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| BNTX | RXRX | |
|---|---|---|
Market Cap | $22.78B | $1.75B |
Sector | Health | Health |
52-Week High | $119.34 | $6.79 |
52-Week Low | $83.89 | $2.84 |
Enterprise Value | $6.45B | $1.17B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
